Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT

This publication has 8 references indexed in Scilit:

• Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
  Annals of Internal Medicine, 2021
• Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
  New England Journal of Medicine, 2021
• Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study
  The Lancet Haematology, 2021
• Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
  The Lancet, 2021
• COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
  Leukemia, 2021
• Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
  Nature Medicine, 2021
• Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
  The Lancet Haematology, 2021
• Antipneumococcal Seroprotection Years After Vaccination in Allogeneic Hematopoietic Cell Transplant Recipients
  Clinical Infectious Diseases, 2019